Skip to content

PREDICTA: predicting asthma attacks in children with asthma using artificial intelligence

PREDICTA: Pediatric Respiratory Exacerbation Detection - Innovating Asthma Care with Techniques of Artificial Intelligence - PREDICTA: Pediatric Respiratory Exacerbation Detection - Innovating Asthma Care with Techniques of Artificial Intelligence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57486
Enrollment
1800
Registered
2025-02-10
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric asthma, asthma, bronchial hyperreactivity, exercise-induced bronchoconstriction

Interventions

The main research product is an AI model capable of predicting asthma exacerbations based on patient data and environmental factors. Furthermore, this model can explain which factors are important for
Additionally, the study will assess how digital tools, such as the Puffer app, can contribute to improved self-management and personalized support for children with asthma.

Sponsors

Medisch Spectrum Twente (MST)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A child with asthma under 18 years old who is under treatment for Asthma in Medisch Spectrum Twente hospital.

Exclusion criteria

Exclusion criteria: Patient does not want his/her data to be used in the research (opt-out).

Design outcomes

Primary

MeasureTime frame
The key outcome of the study is the accuracy of the AI model in predicting asthma exacerbations, which will be evaluated using metrics like:Precision: How often does the model correctly predict an asthma exacerbation?Sensitivity: How well does the model detect actual exacerbations?Specificity: How well does the model identify children who will NOT experience an exacerbation?

Secondary

MeasureTime frame
In addition to evaluating the model’s predictive accuracy, the study will assess:Clinical applicability: How well can the AI model be integrated into routine asthma care?Impact of eHealth data: Does adding home-monitoring and symptom tracking improve predictions?Prediction horizon: How far in advance can the model accurately predict an exacerbation?Acceptance by healthcare professionals: How do doctors and nurses perceive the usability and reliability of AI-assisted asthma care?

Countries

Netherlands

Contacts

Public ContactM.R. van der Kamp

Medisch Spectrum Twente (MST)

kindergeneeskunde@mst.nl(053) 487 23 10

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)